Epigenetic regulation in cancer
MedComm · 2024-02 · 5 (2)
DOI: 10.1002/mco2.495 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 19.02.2024. Verfasst von Minzhi Gu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery Peking Union Medical College Hospital Peking Union Medical College Chinese Academy of Medical Sciences Beijing P. R. Ch…. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Epigenetic modifications are defined as heritable changes in gene activity that do not involve changes in the underlying DNA sequence. The oncogenic process is driven by the accumulation of alterations that impact genome's structure and function. Genetic mutations, which directly disrupt the DNA sequence, are complemented by epigenetic modifications that modulate gene expression, thereby facilitating the acquisition of malignant characteristics. Principals among these epigenetic changes are shifts in DNA methylation and histone mark patterns, which promote tumor development and metastasis. Notably, the reversible nature of epigenetic alterations, as opposed to the permanence of genetic changes, positions the epigenetic machinery as a prime target in the discovery of novel therapeutics. Our review delves into the complexities of epigenetic regulation, exploring its profound effects on tumor initiation, metastatic behavior, metabolic pathways, and the tumor microenvironment. We place a particular emphasis on the dysregulation at each level of epigenetic modulation, including but not limited to, the aberrations in enzymes responsible for DNA methylation and histone modification, subunit loss or fusions in chromatin remodeling complexes, and the disturbances in higher‐order chromatin structure. Finally, we also evaluate therapeutic approaches that leverage the growing understanding of chromatin dysregulation, offering new avenues for cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery Peking Union Medical College Hospital Peking Union Medical College Chinese Academy of Medical Sciences Beijing P. R. China.
- Key Laboratory of Research in Pancreatic Tumor Chinese Academy of Medical Sciences Beijing P. R. China.
- National Science and Technology Key Infrastructure on Translational Medicine in Peking Union Medical College Hospital Beijing P. R. China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gu, M., Ren, B., Fang, Y., Ren, J., Liu, X., Wang, X., Zhou, F., Xiao, R., Luo, X., You, L., & Zhao, Y. (2024). Epigenetic regulation in cancer. MedComm, 5(2). https://doi.org/10.1002/mco2.495
Vancouver
Gu M, Ren B, Fang Y, Ren J, Liu X, Wang X, et al. Epigenetic regulation in cancer. MedComm. 2024;5(2). doi:10.1002/mco2.495
BibTeX
@article{Gu2024,
author = {Gu, Minzhi and Ren, Bo and Fang, Yuan and Ren, Jie and Liu, Xiaohong and Wang, Xing and Zhou, Feihan and Xiao, Ruiling and Luo, Xiyuan and You, Lei and Zhao, Yupei},
title = {Epigenetic regulation in cancer},
journal = {MedComm},
year = {2024},
volume = {5},
number = {2},
doi = {10.1002/mco2.495}
}
EUVIMED